Douglas R. Nemec
concentrates on intellectual property litigation and related counseling, including providing intellectual property advice in connection with corporate transactions.
Mr. Nemec has litigated numerous cases in a wide range of technologies, from pharmaceuticals and other chemicals to IT and electronics. He has particular experience in life sciences matters, including patent litigation under the Hatch-Waxman Act. Mr. Nemec also is registered to practice before the U.S. Patent and Trademark Office, where he represents clients in patent interference proceedings and other matters.
Selected engagements in which Mr. Nemec has served a lead role include:
- representing a clean energy start-up in Lanham Act and state unfair competition claims arising out of false assertions of patent ownership and royalty rights;
- arguing before the U.S. Court of Appeals for the Federal Circuit and representing a pharmaceutical manufacturer in underlying patent interference proceedings before the U.S. Patent and Trademark Office;
- representing the world’s leading manufacturer of intelligent lighting products in multiple matters asserting and defending against claims of patent infringement involving complex optical devices and digital communication systems;
- advising a major pharmaceutical company in formulating licensing strategies for developmental compounds and diagnostic tools; and
- leading the intellectual property aspects of a multibillion-dollar biotechnology company acquisition.